Piperazine urea derivatives as melanocortin-4 receptor agonists
US7414057B2 · kind B2 · utility
1Cited by
9References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 5, 2003 |
| Grant date | Aug 19, 2008 |
| Priority date | — |
| Expiry date | Nov 18, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Certain novel piperazine urea derivatives are agonists of the human melanocortin-4 receptor (MC-4R) and, in particular, are receptor-subtype selective agonists of MC-4R. They are useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity and diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.